Brief: Prokidney Receives Allowance From The Uk Medicines And Healthcare Products Regulatory Agency (Mhra) For Proact 1 (Regen-006) And EMA Scientific Advice On Phase 3 Protocols Of React For Diabetic Chronic Kidney Disease
03/11/2022 10:19
Nov 3 (Reuters) - ProKidney Corp PROK.O :
* PROKIDNEY RECEIVES ALLOWANCE FROM THE UK MEDICINES AND
HEALTHCARE PRODUCTS REGULATORY AGENCY (MHRA) FOR PROACT 1
(REGEN-006) AND EMA SCIENTIFIC ADVICE ON PHASE 3 PROTOCOLS OF
REACT FOR DIABETIC CHRONIC KIDNEY DISEASE
Source text for Eikon: ID:nGNX6Dzl0B
Further company coverage: PROK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prokidney
See all newsProkidney Corp reports results for the quarter ended September 30 - Earnings Summary
ProKidney Q3 loss widens on higher R&D costs
Brief: ProKidney Q3 Operating Income USD -53.758 Million
Brief: Prokidney Corp Enters Open Market Sale Agreement With Jefferies
Cell therapy developer ProKidney's Q2 operating loss widens as trial costs rise